BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27424325)

  • 21. Search for Structural Basis of Interactions of Biogenic Amines with Human TAAR1 and TAAR6 Receptors.
    Glyakina AV; Pavlov CD; Sopova JV; Gainetdinov RR; Leonova EI; Galzitskaya OV
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential of trace amines and their receptors for treating neurological and psychiatric diseases.
    Berry MD
    Rev Recent Clin Trials; 2007 Jan; 2(1):3-19. PubMed ID: 18473983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer's Disease.
    Leo D; Targa G; Espinoza S; Villers A; Gainetdinov RR; Ris L
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elusive amines and primary headaches: historical background and prospectives.
    D'Andrea G; Terrazzino S; Fortin D; Cocco P; Balbi T; Leon A
    Neurol Sci; 2003 May; 24 Suppl 2():S65-7. PubMed ID: 12811595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trace Amines and Trace Amine-Associated Receptors: A New Frontier in Cell Signaling.
    Freyberg Z; Saavedra JM
    Cell Mol Neurobiol; 2020 Mar; 40(2):189-190. PubMed ID: 32006222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands.
    Hu LA; Zhou T; Ahn J; Wang S; Zhou J; Hu Y; Liu Q
    Biochem J; 2009 Oct; 424(1):39-45. PubMed ID: 19725810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiological effects of trace amines on mesencephalic dopaminergic neurons.
    Ledonne A; Berretta N; Davoli A; Rizzo GR; Bernardi G; Mercuri NB
    Front Syst Neurosci; 2011; 5():56. PubMed ID: 21772817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minor Changes in Erythrocyte Osmotic Fragility in Trace Amine-Associated Receptor 5 (TAAR5) Knockout Mice.
    Zhukov IS; Kubarskaya LG; Karpova IV; Vaganova AN; Karpenko MN; Gainetdinov RR
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Public Transcriptomic Data Meta-Analysis Demonstrates TAAR6 Expression in the Mental Disorder-Related Brain Areas in Human and Mouse Brain.
    Vaganova AN; Katolikova NV; Murtazina RZ; Kuvarzin SR; Gainetdinov RR
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trace amine-associated receptors as emerging therapeutic targets.
    Sotnikova TD; Caron MG; Gainetdinov RR
    Mol Pharmacol; 2009 Aug; 76(2):229-35. PubMed ID: 19389919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TAARs as Novel Therapeutic Targets for the Treatment of Depression: A Narrative Review of the Interconnection with Monoamines and Adult Neurogenesis.
    Shemiakova TS; Efimova EV; Gainetdinov RR
    Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane permeability of trace amines: evidence for a regulated, activity-dependent, nonexocytotic, synaptic release.
    Berry MD; Shitut MR; Almousa A; Alcorn J; Tomberli B
    Synapse; 2013 Oct; 67(10):656-67. PubMed ID: 23564683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased dopamine transmission and adult neurogenesis in trace amine-associated receptor 5 (TAAR5) knockout mice.
    Efimova EV; Kozlova AA; Razenkova V; Katolikova NV; Antonova KA; Sotnikova TD; Merkulyeva NS; Veshchitskii AS; Kalinina DS; Korzhevskii DE; Musienko PE; Kanov EV; Gainetdinov RR
    Neuropharmacology; 2021 Jan; 182():108373. PubMed ID: 33132188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biogenic Trace Amine-Associated Receptors (TAARS) are encoded in avian genomes: evidence and possible implications.
    Mueller JC; Steiger S; Fidler AE; Kempenaers B
    J Hered; 2008; 99(2):174-6. PubMed ID: 18296390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Case for TAAR1 as a Modulator of Central Nervous System Function.
    Rutigliano G; Accorroni A; Zucchi R
    Front Pharmacol; 2017; 8():987. PubMed ID: 29375386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rapid functional assay for the human trace amine-associated receptor 1 based on the mobilization of internal calcium.
    Navarro HA; Gilmour BP; Lewin AH
    J Biomol Screen; 2006 Sep; 11(6):688-93. PubMed ID: 16831861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TAAR Agonists.
    Xu Z; Li Q
    Cell Mol Neurobiol; 2020 Mar; 40(2):257-272. PubMed ID: 31848873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trace amines differentially regulate adult locomotor activity, cocaine sensitivity, and female fertility in Drosophila melanogaster.
    Hardie SL; Zhang JX; Hirsh J
    Dev Neurobiol; 2007 Sep; 67(10):1396-405. PubMed ID: 17638385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.
    Bräunig J; Dinter J; Höfig CS; Paisdzior S; Szczepek M; Scheerer P; Rosowski M; Mittag J; Kleinau G; Biebermann H
    Front Pharmacol; 2018; 9():222. PubMed ID: 29593543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders.
    Wu R; Li JX
    CNS Drugs; 2021 Dec; 35(12):1239-1248. PubMed ID: 34766253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.